ES2177927T3 - Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico. - Google Patents

Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico.

Info

Publication number
ES2177927T3
ES2177927T3 ES97902074T ES97902074T ES2177927T3 ES 2177927 T3 ES2177927 T3 ES 2177927T3 ES 97902074 T ES97902074 T ES 97902074T ES 97902074 T ES97902074 T ES 97902074T ES 2177927 T3 ES2177927 T3 ES 2177927T3
Authority
ES
Spain
Prior art keywords
composition
cause
protein antigen
immunological reaction
antigen determinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97902074T
Other languages
English (en)
Spanish (es)
Inventor
Jeffery L Alexander
Shawn Defrees
Alessandro Sette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epimmune Inc
Original Assignee
Epimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epimmune Inc filed Critical Epimmune Inc
Application granted granted Critical
Publication of ES2177927T3 publication Critical patent/ES2177927T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/605—MHC molecules or ligands thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Control Of High-Frequency Heating Circuits (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES97902074T 1996-01-24 1997-01-23 Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico. Expired - Lifetime ES2177927T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1051096P 1996-01-24 1996-01-24

Publications (1)

Publication Number Publication Date
ES2177927T3 true ES2177927T3 (es) 2002-12-16

Family

ID=21746084

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97902074T Expired - Lifetime ES2177927T3 (es) 1996-01-24 1997-01-23 Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico.

Country Status (12)

Country Link
EP (1) EP0876398B1 (2)
JP (1) JP4063879B2 (2)
CN (1) CN1214051A (2)
AT (1) ATE220687T1 (2)
AU (1) AU1582797A (2)
BR (1) BR9710404A (2)
CA (1) CA2242878C (2)
DE (1) DE69714011T2 (2)
DK (1) DK0876398T3 (2)
ES (1) ES2177927T3 (2)
PT (1) PT876398E (2)
WO (1) WO1997026784A1 (2)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528061B1 (en) * 1997-09-04 2003-03-04 Pasteur Institut Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
EP1903056A3 (en) 2002-12-10 2008-05-07 Idm Pharma, Inc. HLA-A1, -A2 -A3, -A24, -B7, and -B44 binding peptides comprising tumor associated antigen epitopes, and compositions thereof
AU2003285280A1 (en) * 2002-12-11 2004-06-30 Pharmexa A/S Targeting single epitopes
ES2456666T3 (es) 2003-04-18 2014-04-23 Biotech Synergy, Inc. Péptidos antígenos HLA-A2 asociados a un tumor y composiciones
ES2310072B1 (es) 2005-12-23 2009-11-16 Proyecto De Biomedicina Cima, S.L. Nuevos peptidos determinantes antigenicos t colaboradores (/dth).
US20110165067A1 (en) * 2007-08-17 2011-07-07 University Of Maryland Office Of Technology Commercialization Carbohydrate functionalized catanionic surfactant vesicles for drug delivery
EP2391635B1 (en) * 2009-01-28 2017-04-26 Epimmune Inc. Pan-dr binding polypeptides and uses thereof
WO2012123269A1 (en) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Immunogenic compositions and methods for their use
EP2980097A4 (en) * 2013-03-29 2017-03-08 Sumitomo Dainippon Pharma Co., Ltd. Conjugate vaccine using trimming function of erap1
MY171854A (en) 2013-03-29 2019-11-05 Sumitomo Dainippon Pharma Co Ltd Wt1 antigen peptide conjugate vaccine
AU2014296038B2 (en) 2013-07-31 2020-09-10 Bioventures, Llc. Compositions for and methods of treating and preventing cancer targeting tumor associated carbohydrate antigens
EP3119424A4 (en) * 2014-03-19 2017-09-13 MacKay Medical Foundation the Presbyterian Church in Taiwan MacKay Memorial Hospital Immunogenic glycopeptides, composition comprising the glycopeptides and use thereof
EP3549957A4 (en) 2016-11-30 2020-08-05 Sumitomo Dainippon Pharma Co., Ltd. AUXILIARY PEPTIDE WT1, AND COMBINATION OF DUDIT PEPTIDE AND CONJUGATE PEPTIDE ANTIGENIC FOR CANCER
CN107141355B (zh) * 2017-05-31 2021-05-14 中国人民解放军第四军医大学 一种htnv抗原表位线性串联多肽及表位肽-复合物四聚体和应用
CN109991422A (zh) * 2017-12-29 2019-07-09 复旦大学 基于特异抗血清的棕榈酰化修饰蛋白质的检测方法
WO2021228853A1 (en) 2020-05-11 2021-11-18 Ose Immunotherapeutics Vaccine against sars-cov virus
CA3189004A1 (en) 2020-07-22 2022-01-27 3H Bio. Co., Ltd. A peptide used for immunotherapeutics
KR102261457B1 (ko) * 2020-07-22 2021-06-09 (주)쓰리에이치바이오 면역 치료제용 펩타이드
WO2022268916A2 (en) 2021-06-23 2022-12-29 Ose Immunotherapeutics Pan-coronavirus peptide vaccine
EP4508068A4 (en) 2022-04-14 2026-04-22 Hospital For Sick Children PFCSP-BASED IMMUNOGENS AND ASSOCIATED COMPOSITION AND METHODS
WO2025093541A1 (en) 2023-10-31 2025-05-08 Ose Immunotherapeutics Combination of interleukin 7 and tumour associated antigen vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1118572A (zh) * 1993-03-05 1996-03-13 萨依特尔有限公司 Hla-a2.1组合肽及其用途
AU698962B2 (en) * 1993-09-14 1998-11-12 Epimmune, Inc. Alteration of immune response using pan DR-binding peptides

Also Published As

Publication number Publication date
JP2000504328A (ja) 2000-04-11
WO1997026784A1 (en) 1997-07-31
ATE220687T1 (de) 2002-08-15
DE69714011T2 (de) 2003-02-27
EP0876398B1 (en) 2002-07-17
DE69714011D1 (de) 2002-08-22
JP4063879B2 (ja) 2008-03-19
PT876398E (pt) 2002-12-31
BR9710404A (pt) 1999-08-17
DK0876398T3 (da) 2002-08-12
CA2242878A1 (en) 1997-07-31
EP0876398A1 (en) 1998-11-11
AU1582797A (en) 1997-08-20
CN1214051A (zh) 1999-04-14
CA2242878C (en) 2010-06-22

Similar Documents

Publication Publication Date Title
ES2177927T3 (es) Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico.
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
GB9713156D0 (en) Vaccines
DK1104306T3 (da) Præparater af CpG- og saponinadjuvanser og fremgangsmåder til anvendelse deraf
EP2481422A3 (en) Multiplex vaccines
PL1635863T3 (pl) Kompozycje do wywoływania, wzmacniania i utrzymywania odpowiedzi immunologicznych na epitopy ograniczone do MHC klasy I do celów profilaktycznych i leczniczych
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
NO20015073L (no) Vaksiner
ATE529130T1 (de) Trockenformulierung für transkutane immunisierung
DE69536091D1 (de) Immunisierung durch Impfung von DNS Transkriptionseinheit
DK2181715T3 (da) Kunstige T-hjælpecelle-epitoper som immunstimulatorer for syntetiske peptidimmunogener
DK1459766T3 (da) Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner
AU3847801A (en) Proteosome influenza vaccine
TW200515916A (en) Chimeric antigens for breaking host tolerance to foreign antigens
NZ331651A (en) BSW17 peptide immunogens for vaccination against and treatment of allergy
GB0123580D0 (en) Vaccine
WO2003084467A3 (en) Epitope constructs comprising antigen presenting cell targeting mechanisms
DK1267924T3 (da) Immunterapeutiske metoder og sammensætninger
BR0111834A (pt) Composições adjuvante e imunogênica, e, método para eliciar uma resposta imune a um antìgeno
ATE370745T1 (de) Verbesserte polysaccharid- und glykokonjugat- vakzine
BR0010711A (pt) Uso de moléculas co-estimulatórias solúveis para intensificar respostas imunes
WO2003006055A8 (en) Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit
WO2002032455A3 (en) Vaccine
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung